A drug that activates the protein LAG-3 (Lymphocyte Activation Gene-3) used to increase immune response to tumors and treat end-stage breast cancer. Eftilagimod alpha (LAG-3Ig or IMP321)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.